Yuyu Pharma Launches First Generic of Migraine Treatment 'Nagrangukangbunghaejeong'

Medication Possible Without Water... Enhancing Patient Convenience

Nagrang Oral Disintegrating Tablet. [Photo by Yuyu Pharmaceutical]

[Asia Economy Reporter Lee Gwan-joo] Yuyu Pharmaceutical announced on the 3rd that it has launched 'Nagran Oral Disintegrating Tablets,' a first generic drug containing naratriptan for the treatment of acute migraine.

Nagran Oral Disintegrating Tablets are prescribed for the rapid relief of migraines with or without aura. The oral disintegrating formulation is placed on the tongue and dissolved by saliva before swallowing, enhancing convenience for migraine patients who can take the medication without water during daily activities.

Following the launch of Migran Tablets (containing sumatriptan) for acute migraine treatment in 2019, Yuyu Pharmaceutical expanded its migraine treatment lineup by releasing Nagran Oral Disintegrating Tablets as a first generic with a formulation differentiated from the original.

Sun Min-hee, PM of Yuyu Pharmaceutical's ETC Marketing Headquarters, said, "The launch of the first generic Nagran Oral Disintegrating Tablets will be an opportunity for Yuyu Pharmaceutical to gain a competitive edge in the fierce migraine treatment market," adding, "Yuyu Pharmaceutical plans to carry out various activities to improve awareness of migraine disorders through continuous communication with neurologists and headache specialists."

Meanwhile, the insurance reimbursement price per tablet of Nagran Oral Disintegrating Tablets has been registered at 3,686 KRW.

This content was produced with the assistance of AI translation services.